JP3428850006
JP3428850006
ZERIA PHARMACEUTICAL
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2026 | 2025 | Change % |
|---|---|---|---|
| Total Revenue | 89.159.262.000 | 87.311.137.000 | 2.1% |
| Cost of Revenue | 23.976.621.000 | 23.351.451.000 | 2.7% |
| Gross Profit | 65.182.641.000 | 63.959.686.000 | 1.9% |
| 52.808.195.000 | 51.762.100.000 | 2.0% | |
| Operating Income | 12.374.446.000 | 12.197.586.000 | 1.4% |
| Pretax Income | 11.200.113.000 | 12.618.613.000 | 11.2% |
| Net Income Common Stockholders | 8.454.544.000 | 9.936.323.000 | 14.9% |
| -- | -- | -- | |
| -- | -- | -- |